Cite
HARVARD Citation
Sandborn, W. et al. (2022). Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open‐label, long‐term extension study with up to 7.0 years of treatment. Alimentary pharmacology & therapeutics. 55 (4), pp. 464-478. [Online].